Professor Ayman El-Hattab has the American boards in Pediatrics, Clinical Genetics, and Biochemical Genetics. He is fellow member of the American Academy of Pediatrics and the American College of Medical Genetics. In addition, he is a member of the American Society of Human Genetics, the United Mitochondrial Disease Foundation, the European Society of Human Genetics, the Society for the Study of Inborn Errors of Metabolism, and the Society for Inherited Metabolic Disorders.

Professor El-Hattab has more than 15 years of experience in the field of clinical genetics. He worked at Baylor College of Medicine and University of Missouri in USA, King Fahad Medical City in Saudi Arabia, and he has been working in several hospitals in United Arab Emirates (https://geneticsclinics.ae/).

Professor El-Hattab is heavily involved in research. He conducted many clinical research projects, and he has more than 120 publications, several book chapters, and many presentations in scientific conferences. Dr. El-Hattab’s research fields include chromosomal abnormalities, metabolic disorders, neurogenetic diseases, novel gene and syndrome discovery, and mitochondrial diseases. Professor El-Hattab has received several awards, and he was designated as one of the world’s top 2% scientists by Stanford University, USA in the report published in October 2020.

Dr. El-Hattab is also the Founder and President of MENA Organization for Rare Diseases which was established in UAE to advocate for rare diseases in the Middle East and North Africa (MENA) region. The goals of the organization are to educate, connect, and support. The organization aims at spreading knowledge and increasing awareness about rare diseases among healthcare providers, patients and families, and the public through conferences and meetings, social media, and online newsletters and educational webpages.